These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4986989)

  • 1. [Course of plasma glucose, fatty acids and glycerol in 10 treated cases of severe diabetic acido-ketosis].
    Dauchy F; Protin P; Assan R; Fabiani P
    Ann Biol Clin (Paris); 1970; 28(1):55-8. PubMed ID: 4986989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolution of hormonal parameters (glucagon, cortisol, growth hormone) and energetic parameters (glucose, fatty acids, free glycerol) in 10 severe cases of diabetic acido-ketosis under treatment].
    Assan R; Hautecouverture G; Guillemant S; Dauchy F; Protin P; Derot M
    Pathol Biol (Paris); 1969 Dec; 17(23):1095-105. PubMed ID: 4985195
    [No Abstract]   [Full Text] [Related]  

  • 3. Serial plasma growth hormone levels in 33 cases of severe diabetic ketoacidosis--effects of sodium nicotinate.
    Assan R; Tchobroutsky G
    Horm Metab Res; 1972 Sep; 4(5):317-21. PubMed ID: 4630328
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma-levels of glucose, non-esterified fatty acid, glycerol, and insulin four years before the onset of diabetic ketosis.
    Hales CN
    Lancet; 1967 Aug; 2(7512):389-90. PubMed ID: 4166333
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactic acidosis complicating diabetic ketosis in a patient with hyperthyroidism.
    De Troyer A; Naeije R; Clumeck N; Balasse EO
    Diabete Metab; 1977 Mar; 3(1):23-6. PubMed ID: 404202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-dose insulin therapy for diabetic keto-acidosis. 11 consecutive treated cases].
    Eskildsen PC; Nerup J
    Ugeskr Laeger; 1976 Jun; 138(25):1499-504. PubMed ID: 820027
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and biochemical status in diabetic ketoacidosis treated with low dose insulin infusion.
    Sachdev Y
    J Assoc Physicians India; 1983 Oct; 31(10):621-4. PubMed ID: 6423618
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the concentration of H+-ions and the efficiency of insulin in the treatment of diabetic ketoacidosis.
    Ionescu-Tîrgovişte C; Mincu I; Cheţa D
    Endokrinologie; 1980 Oct; 76(2):171-80. PubMed ID: 6778693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of glycerol].
    Khattab M; Abu Essa H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):197-204. PubMed ID: 4212705
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of diabetic keto-acidosis through continuous insulin infusion].
    Mirouze J; Mion C; Monnier L; Beraud JJ; Selam JL
    Nouv Presse Med; 1976 Nov; 5(37):2444-6. PubMed ID: 824621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the effect of insulin by DL-4 (2-hydroxy-3-isopropylaminopropoxy)-indole (Visken, LB 46) in normal and diabetic persons].
    Lisch HJ; Sailer S; Sandhofer F; Braunsteiner H
    Schweiz Med Wochenschr; 1972 Apr; 102(14):510-4. PubMed ID: 5019768
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic acido-ketosis].
    Boukhris R; Ben Slama C; Mebazaa A
    Tunis Med; 1982; 60(4):128-33. PubMed ID: 6821452
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of control of hyperglycemia on plasma insulin responses to various stimuli in newly diagnosed ketosis-prone diabetic patients.
    Foucar E; Field JB
    J Clin Endocrinol Metab; 1972 Aug; 35(2):288-98. PubMed ID: 4627325
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of diabetic ketoacidosis.
    Allain TJ
    Cent Afr J Med; 1994 Oct; 40(10):289-91. PubMed ID: 7828182
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction of ketosis by suppression of lipolysis with 5-methylpyrazole-3-carboxylic acid in rats with established diabetic ketoacidosis.
    Axelrod L; Lloyd-Jones P; Martin DB
    Diabetes; 1979 Jul; 28(7):651-7. PubMed ID: 109341
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic diabetic ketoacidosis in pregnancy.
    Tarif N; Al Badr W
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):590-3. PubMed ID: 17951948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment with insulin or diet on intermediary metabolites in pregnant women with chemical diabetes in the third trimester of pregnancy.
    Stangenberg M; Persson B; Lunell NO; Hanson U
    Acta Diabetol Lat; 1984; 21(1):55-61. PubMed ID: 6375226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
    Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
    Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.